Chardon Pharma created its fourth spin-off company: Hairstressor BV. Hairstressor BV is a service company that analyses stress hormone levels in hair from animals and humans.
Chardon Pharma created its third spin-off company: Orexa BV. Orexa BV develops a series of pharmaceutical products to prevent and treat malnutrition.
Chardon Pharma created its second spin-off company: Digest-Inn BV. Digest-Inn BV develops an applied game for the treatment of obesity.
Chardon Pharma won the Investors lounge at the annual Health Valley event.
Chardon Pharma created its first spin-off company: E-Assyst BV. E-Assyst BV develops an e-health solution to support the treatment of gambling addiction.
Chardon Pharma started a clinical study in endometriosis patiënts to characterize and quantify pain complaints. The study is a collaboration with the Rijnstate hospital in Arnhem and the Radboud University in Nijmegen.
Chardon Pharma filed its third patent, entitled: ‘Use of selected N-phenyl benzamide variants for the stimulation of osteoblast activity and for the treatment of Osteoporosis and related disorders.’
Patent: Means to facilitate food intake and food retention (pdf)
Chardon Pharma opened its zebrafish research facility in Mercator III (Toernooiveld 1, 6525 EC Nijmegen. The Netherlands).
Chardon Pharma filed its second patent entitled: ‘A method to measure therapeutic effects of a compound on bone formation or degradation’.